Exclusive

Publication

Byline

Location

Clinical Trial: A single-center prospective observational study evaluating the usefulness of gel immersion endoscopy in difficult colorectal stent placement for obstructive colorectal cancer (Japan)

Tokyo, June 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061800) titled 'Prospective observational study evaluating the usefulness of gel immersion e... Read More


Clinical Trial: Educational Effectiveness of AI-Based Feedback in Early Upper Gastrointestinal Endoscopy Training for Non-Expert Endoscopists: A Non-Inferiority Randomized Controlled Trial Based on Completeness of Mucosal Visualization and Image Quality (Japan)

Tokyo, June 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061701) titled 'Study on the Educational Effectiveness of AI-Based Feedback in Upper Gastroi... Read More


Clinical Trial: A Study on the Feasibility of Pelvic Floor Muscle Training Using a Training Device for Elderly Patients with Urinary Incontinence (Japan)

Tokyo, June 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061555) titled 'A Study on the Feasibility of Pelvic Floor Muscle Training Using a Training ... Read More


Clinical Trial: Effects of Postprandial Stretching on Blood Glucose Responses (Japan)

Tokyo, June 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061410) titled 'Effects of Postprandial Stretching on Blood Glucose Responses' on June 8. S... Read More


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 7 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... Read More


Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 7 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... Read More


Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, June 7 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, June 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, June 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, June 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More